"With less than five percent of all federal funding for stem cell research going to embryonic stem cell research, it should come as no surprise that advances in adult stem cell science fill scientific journals. It's exactly why we urge lawmakers to pass H.R. 3 and S. 5 to allow America's best scientists to fully explore all avenues of research. Scientists, including those whose work the White House touts, agree that embryonic research shows great promise for better treatments and cures for the 100 million Americans suffering from cancer, diabetes, Parkinson's, Alzheimer's, spinal cord injuries, and other debilitating diseases and disorders.

"Today's White House Domestic Policy Office report is a thinly veiled attempt to derail legislation that has overwhelming bipartisan support in the House and Senate, and among the American people. Nearly three-quarters of Americans support embryonic stem cell research, and the November elections were a clear sound-off from voters that they are fed up with ideological-driven policy. It’s sad that rather than seek the best scientific information, the White House does not attempt to examine the latest in embryonic stem cell science. It's time for federal policy to be based upon what the facts ARE, not what the White House wishes they were.
"CAMR supports all forms research in regenerative medicine and believes that federal policy should allow for funding and oversight of embryonic stem cell research. We look forward to working with both chambers of Congress in the next few weeks to effect change in the federal policy in this arena."

--Sean Tipton, President, CAMR